Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2010

Open Access 01-12-2010 | Research

Disassociated relation between plasma tumor necrosis factor-α, interleukin-6 and increased body weight in Amerindian women: A long-term prospective study of natural body weight variation and impaired glucose tolerance

Authors: Folke Lindgärde, Anders Gottsäter, Bo Ahrén

Published in: Diabetology & Metabolic Syndrome | Issue 1/2010

Login to get access

Abstract

Background

Inflammatory cytokines are linked to obesity-related insulin resistance and may predict type 2 diabetes independently of obesity. We previously reported that a majority of a cohort of 73 non-diabetic women with normal plasma (p-)glucose with Amerindian heritage in Lima, Peru, during a 5-year period increased both body weight and p-glucose levels, yet p-insulin was unaltered. A high proportion of palmitoleic acid (16:1n-7) in serum (s) and systolic blood pressure (SBP) were independent predictors of high p-glucose. Whether cytokines also contributed is, however, not known.

Methods

During 5 years we prospectively investigated the relation between changed concentrations of p-tumor necrosis factor (TNF)-α, p-interleukin (IL)-6 and circulating insulin and glucose in relation to the natural variation of body weight. Study variables included anthropometric measurements, p-insulin, TNF-α, IL-6, SBP and the proportion of 16:1n-7 in s-fatty acid composition.

Results

Weight and waist differences correlated negatively to the difference in p-TNF-α but positively to differences in p-IL-6 and p-insulin, whereas the increase of p-glucose from baseline to follow-up did not correlate with changes in levels of the two cytokines. In multiple regression analysis changes of TNF-α and insulin contributed independently to the variance in weight. P-insulin at baseline and weight change were determinants of fasting p-insulin at follow-up. Multiple regression analysis revealed that weight change (t-value = - 2.42; P = 0.018) and waist change (t-value = 2.41; P = 0.019) together with S-16:1n-7 (p < 0.0001) and SBP (p = 0.0005) at baseline were significant predictors of p-glucose at follow-up.

Conclusion

Our prospective study of Amerindian women revealed disassociations between changes in p-TNF-α and p-IL-6 in relation to variation in body weight. A high proportion of s-16:1n-7, SBP at baseline together with weight and waist changes were independent predictors of p-glucose at follow-up. The exact role of the opposite effects and clinical impact of p-TNF-α and p-IL-6 on loss and gain of body weight and indirectly on the development of glucose intolerance is not known.
Literature
1.
go back to reference Lindgärde F, Söderberg S, Olsson T, Ercilla MB, Correa LR, Ahrén B: Overweight is associated with lower serum leptin in Peruvian Indian than in Caucasian women: a dissociation contributing to low blood pressure. Metabolism. 2001, 50: 325-329. 10.1053/meta.2001.21033.CrossRefPubMed Lindgärde F, Söderberg S, Olsson T, Ercilla MB, Correa LR, Ahrén B: Overweight is associated with lower serum leptin in Peruvian Indian than in Caucasian women: a dissociation contributing to low blood pressure. Metabolism. 2001, 50: 325-329. 10.1053/meta.2001.21033.CrossRefPubMed
2.
go back to reference Lindgärde F, Ahrén B: Improved metabolic risk markers following two 6-month physical activity programs among socioeconomic marginalized women of native American ancestry in Lima, Peru. Diabetes Care. 2007, 30: 2230-2233. 10.2337/dc06-2633.CrossRefPubMed Lindgärde F, Ahrén B: Improved metabolic risk markers following two 6-month physical activity programs among socioeconomic marginalized women of native American ancestry in Lima, Peru. Diabetes Care. 2007, 30: 2230-2233. 10.2337/dc06-2633.CrossRefPubMed
3.
go back to reference Lindgärde F, Vessby B, Ahrén B: Serum cholesteryl fatty acid composition and plasma glucose concentrations in Amerindian women. Am J Clin Nutr. 2006, 84: 1009-1013.PubMed Lindgärde F, Vessby B, Ahrén B: Serum cholesteryl fatty acid composition and plasma glucose concentrations in Amerindian women. Am J Clin Nutr. 2006, 84: 1009-1013.PubMed
4.
go back to reference Duncan BB, Schmidt MI, Chamb less LE, Folsom AR, Carpenter M, Heiss G: Fibrinogen, other putative markers of inflammation, and weight gain in middle-aged adults: the ARIC study: Atherosclerosis Risk in Communities. Obes Res. 2000, 8: 279-286. 10.1038/oby.2000.33.CrossRefPubMed Duncan BB, Schmidt MI, Chamb less LE, Folsom AR, Carpenter M, Heiss G: Fibrinogen, other putative markers of inflammation, and weight gain in middle-aged adults: the ARIC study: Atherosclerosis Risk in Communities. Obes Res. 2000, 8: 279-286. 10.1038/oby.2000.33.CrossRefPubMed
5.
go back to reference Hajer GR, van Haeften TW, Visseren FL: Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J. 2008, 29: 2959-2971. 10.1093/eurheartj/ehn387.CrossRefPubMed Hajer GR, van Haeften TW, Visseren FL: Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J. 2008, 29: 2959-2971. 10.1093/eurheartj/ehn387.CrossRefPubMed
6.
go back to reference Engström G, Hedblad B, Eriksson KF, Janzon L, Lindgärde F: Complement C3 is a risk factor for the development of diabetes. A population-based cohort study. Diabetes. 2005, 54: 570-575. 10.2337/diabetes.54.2.570.CrossRefPubMed Engström G, Hedblad B, Eriksson KF, Janzon L, Lindgärde F: Complement C3 is a risk factor for the development of diabetes. A population-based cohort study. Diabetes. 2005, 54: 570-575. 10.2337/diabetes.54.2.570.CrossRefPubMed
7.
go back to reference Engström G, Hedblad B, Stavenow L, Lind P, Janzon L, Lindgärde F: Inflammation-sensitive plasma proteins are associated with future weight-gain. Diabetes. 2003, 52: 2097-2101. 10.2337/diabetes.52.8.2097.CrossRefPubMed Engström G, Hedblad B, Stavenow L, Lind P, Janzon L, Lindgärde F: Inflammation-sensitive plasma proteins are associated with future weight-gain. Diabetes. 2003, 52: 2097-2101. 10.2337/diabetes.52.8.2097.CrossRefPubMed
8.
go back to reference Grunnet L, Poulsen P, Pedersen Klarlund B, Mandrup-Poulsen T, Vaag A: Plasma cytokine levels in young and elderly twins: genes versus environment and relation to in vivo insulin action. Diabetologia. 2006, 49: 343-350. 10.1007/s00125-005-0080-8.CrossRefPubMed Grunnet L, Poulsen P, Pedersen Klarlund B, Mandrup-Poulsen T, Vaag A: Plasma cytokine levels in young and elderly twins: genes versus environment and relation to in vivo insulin action. Diabetologia. 2006, 49: 343-350. 10.1007/s00125-005-0080-8.CrossRefPubMed
9.
go back to reference Carey AL, Bruce CR, Sacchetti M, et al: Interleukin-6 and tumor necrosis factor-alpha are not increased in patients with Type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness. Diabetologia. 2004, 47: 1029-1037.PubMed Carey AL, Bruce CR, Sacchetti M, et al: Interleukin-6 and tumor necrosis factor-alpha are not increased in patients with Type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness. Diabetologia. 2004, 47: 1029-1037.PubMed
10.
go back to reference Endo M, Masaki T, Seike M, Yoshimatsu M: Involvement of stomac gherlin and hypothalamic neuropeptides in tumor necrosis factor-alpha-induced hypophagia in mice. Regul Pept. 2007, 140: 94-100. 10.1016/j.regpep.2006.11.022.CrossRefPubMed Endo M, Masaki T, Seike M, Yoshimatsu M: Involvement of stomac gherlin and hypothalamic neuropeptides in tumor necrosis factor-alpha-induced hypophagia in mice. Regul Pept. 2007, 140: 94-100. 10.1016/j.regpep.2006.11.022.CrossRefPubMed
11.
go back to reference Meguid MM, Fetissov SO, Vendrell J, et al: Hypothalamic dopamine and serotonin in the regulation of food intake. Nutrition. 2000, 16: 843-857. 10.1016/S0899-9007(00)00449-4.CrossRefPubMed Meguid MM, Fetissov SO, Vendrell J, et al: Hypothalamic dopamine and serotonin in the regulation of food intake. Nutrition. 2000, 16: 843-857. 10.1016/S0899-9007(00)00449-4.CrossRefPubMed
12.
go back to reference Hsu F-C, Kritchevsky S, Liu Y, et al: Association between inflammatory components and physical function in the health, aging, and body composition study: a principal component analysis approach. J Gerontol A Biol Sci Med Sc. 2009, 64: 581-589.CrossRef Hsu F-C, Kritchevsky S, Liu Y, et al: Association between inflammatory components and physical function in the health, aging, and body composition study: a principal component analysis approach. J Gerontol A Biol Sci Med Sc. 2009, 64: 581-589.CrossRef
13.
go back to reference Schaap LA, Pluijm SM, Deeg DJ, et al: Higher inflammatory Marker Levels in Older Persons: Associations With 5-Year Change in Muscle Mass and Muscle Strength. J Gerontol Biol Sci Med Sci. 2009, 64: 1183-1189.CrossRef Schaap LA, Pluijm SM, Deeg DJ, et al: Higher inflammatory Marker Levels in Older Persons: Associations With 5-Year Change in Muscle Mass and Muscle Strength. J Gerontol Biol Sci Med Sci. 2009, 64: 1183-1189.CrossRef
14.
go back to reference Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turnerer RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28: 412-419. 10.1007/BF00280883.CrossRefPubMed Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turnerer RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28: 412-419. 10.1007/BF00280883.CrossRefPubMed
15.
go back to reference Barani J, Nilsson JÅ, Mattiasson I, Lindblad B, Gottsäter A: Inflammatory mediators are associated with 1-year mortality in critical limb ischemia. J Vasc Surg. 2005, 42: 75-80. 10.1016/j.jvs.2005.03.025.CrossRefPubMed Barani J, Nilsson JÅ, Mattiasson I, Lindblad B, Gottsäter A: Inflammatory mediators are associated with 1-year mortality in critical limb ischemia. J Vasc Surg. 2005, 42: 75-80. 10.1016/j.jvs.2005.03.025.CrossRefPubMed
16.
go back to reference Boberg M, Croon LB, Gustafsson IB, Vessby B: Platelet fatty acid composition in relation to fatty acid composition in plasma and to s-lipoprotein lipids in healthy subjects with special reference to the linoleic acid pathway. Clin Sci. 1985, 68: 581-587.CrossRefPubMed Boberg M, Croon LB, Gustafsson IB, Vessby B: Platelet fatty acid composition in relation to fatty acid composition in plasma and to s-lipoprotein lipids in healthy subjects with special reference to the linoleic acid pathway. Clin Sci. 1985, 68: 581-587.CrossRefPubMed
17.
go back to reference Knowler WC, Pettitt DJ, Saad MF, Bennett PH: Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. Diabetes Metab Rev. 1990, 6: 1-27. 10.1002/dmr.5610060101.CrossRefPubMed Knowler WC, Pettitt DJ, Saad MF, Bennett PH: Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. Diabetes Metab Rev. 1990, 6: 1-27. 10.1002/dmr.5610060101.CrossRefPubMed
18.
go back to reference Jacoby E, Goldstein J, Lopez A, Nunez E, Lopez T: Social class, family, and life-style factors associated with overweight and obesity among adults in Peruvian cities. Prev Med. 2003, 37: 396-405. 10.1016/S0091-7435(03)00159-2.CrossRefPubMed Jacoby E, Goldstein J, Lopez A, Nunez E, Lopez T: Social class, family, and life-style factors associated with overweight and obesity among adults in Peruvian cities. Prev Med. 2003, 37: 396-405. 10.1016/S0091-7435(03)00159-2.CrossRefPubMed
19.
go back to reference Rasmussen SS, Glümer C, Sandbaek A, Lauritzen T, Borch-Johnsen K: Determinants of progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screened population: 3 year follow-up in the ADDITION study, Denmark. Diabetologia. 2008, 51: 249-257. 10.1007/s00125-007-0893-8.CrossRefPubMed Rasmussen SS, Glümer C, Sandbaek A, Lauritzen T, Borch-Johnsen K: Determinants of progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screened population: 3 year follow-up in the ADDITION study, Denmark. Diabetologia. 2008, 51: 249-257. 10.1007/s00125-007-0893-8.CrossRefPubMed
20.
go back to reference Kusenova M, Hainer V, Tvrzicka E, et al: Assessment of dietary and genetic factors influencing serum and adipose fatty acid composition in obese female identical twins. Lipids. 2002, 37: 27-32. 10.1007/s11745-002-0860-z.CrossRef Kusenova M, Hainer V, Tvrzicka E, et al: Assessment of dietary and genetic factors influencing serum and adipose fatty acid composition in obese female identical twins. Lipids. 2002, 37: 27-32. 10.1007/s11745-002-0860-z.CrossRef
21.
go back to reference Clement K, Viguerie N, Poitou C, et al: Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J. 2004, 18: 1657-1669. 10.1096/fj.04-2204com.CrossRefPubMed Clement K, Viguerie N, Poitou C, et al: Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J. 2004, 18: 1657-1669. 10.1096/fj.04-2204com.CrossRefPubMed
22.
go back to reference Puglisi MJ, Fernandez ML: Modulation of C-reactive protein, tumor necrosis factor-alpha, and adiponectin by diet, exercise, and weight loss. J Nutr. 2008, 138: 2293-2296. 10.3945/jn.108.097188.CrossRefPubMed Puglisi MJ, Fernandez ML: Modulation of C-reactive protein, tumor necrosis factor-alpha, and adiponectin by diet, exercise, and weight loss. J Nutr. 2008, 138: 2293-2296. 10.3945/jn.108.097188.CrossRefPubMed
23.
go back to reference Samuelsson L, Gottsäter A, Lindgärde F: Decreasing levels of tumour necrosis factor alpha and interleukin 6 during lowering of body mass index with orlistat or placebo in obese subjects with cardiovascular risk factors. Diabetes Obes Metab. 2003, 3: 195-201. 10.1046/j.1463-1326.2003.00264.x.CrossRef Samuelsson L, Gottsäter A, Lindgärde F: Decreasing levels of tumour necrosis factor alpha and interleukin 6 during lowering of body mass index with orlistat or placebo in obese subjects with cardiovascular risk factors. Diabetes Obes Metab. 2003, 3: 195-201. 10.1046/j.1463-1326.2003.00264.x.CrossRef
24.
go back to reference Tisdale MJ: Biology of cachexia. Jrl Nat Cancer Inst. 1997, 89: 1763-1773. 10.1093/jnci/89.23.1763.CrossRef Tisdale MJ: Biology of cachexia. Jrl Nat Cancer Inst. 1997, 89: 1763-1773. 10.1093/jnci/89.23.1763.CrossRef
25.
go back to reference Pamir N, McMillen TS, Kaiyala KJ, Schwartz MW, LeBoeuf RC: Receptors for tumor necrosis factor-α play a protective role against obesity and alter adipose tissue macrophage status. Endocrinology. 2009, 150: 4124-4134. 10.1210/en.2009-0137.PubMedCentralCrossRefPubMed Pamir N, McMillen TS, Kaiyala KJ, Schwartz MW, LeBoeuf RC: Receptors for tumor necrosis factor-α play a protective role against obesity and alter adipose tissue macrophage status. Endocrinology. 2009, 150: 4124-4134. 10.1210/en.2009-0137.PubMedCentralCrossRefPubMed
26.
go back to reference Xu H, Hirosumi J, Uysal KT, Guler AD, Hotamisligil GS: Exclusive action of transmembrane TNF -α in adipose tissue leads to reduced adipose mass and local but not systemic insulin resistance. Endocrinology. 2002, 143: 1502-1511. 10.1210/en.143.4.1502.PubMed Xu H, Hirosumi J, Uysal KT, Guler AD, Hotamisligil GS: Exclusive action of transmembrane TNF -α in adipose tissue leads to reduced adipose mass and local but not systemic insulin resistance. Endocrinology. 2002, 143: 1502-1511. 10.1210/en.143.4.1502.PubMed
27.
go back to reference Sadagurski M, Norquay L, Farhang J, D'Aquino K, Copps K, White MF: Human IL6 enhances leptin action in mice. Diabetologia. 2010, 53: 525-535. 10.1007/s00125-009-1580-8.PubMedCentralCrossRefPubMed Sadagurski M, Norquay L, Farhang J, D'Aquino K, Copps K, White MF: Human IL6 enhances leptin action in mice. Diabetologia. 2010, 53: 525-535. 10.1007/s00125-009-1580-8.PubMedCentralCrossRefPubMed
28.
go back to reference Aguirre V, Uchida T, Yenush L, Davis R, White MF: The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem. 2000, 24: 9047-9054. 10.1074/jbc.275.12.9047.CrossRef Aguirre V, Uchida T, Yenush L, Davis R, White MF: The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem. 2000, 24: 9047-9054. 10.1074/jbc.275.12.9047.CrossRef
29.
go back to reference Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM: IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science. 1996, 271: 665-668. 10.1126/science.271.5249.665.CrossRefPubMed Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM: IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science. 1996, 271: 665-668. 10.1126/science.271.5249.665.CrossRefPubMed
30.
go back to reference Ruan H, Hachoen N, Golub TR, Van Parijs L, Lodish HF: Tumor necrosis factor alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes; nuclear factor-kappaB activation by TNF-alpha is obligatory. Diabetes. 2002, 51: 1319-1336. 10.2337/diabetes.51.5.1319.CrossRefPubMed Ruan H, Hachoen N, Golub TR, Van Parijs L, Lodish HF: Tumor necrosis factor alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes; nuclear factor-kappaB activation by TNF-alpha is obligatory. Diabetes. 2002, 51: 1319-1336. 10.2337/diabetes.51.5.1319.CrossRefPubMed
31.
go back to reference Tang T, Zhang J, Yin J, et al: Uncoupling of inflammation and insulin resistance by NF-kappaB in transgenic mice through elevated energy expenditure. J Biol Chem. 2010, 285: 4637-4644. 10.1074/jbc.M109.068007.PubMedCentralCrossRefPubMed Tang T, Zhang J, Yin J, et al: Uncoupling of inflammation and insulin resistance by NF-kappaB in transgenic mice through elevated energy expenditure. J Biol Chem. 2010, 285: 4637-4644. 10.1074/jbc.M109.068007.PubMedCentralCrossRefPubMed
32.
go back to reference Chan JCN, Cheung JCK, Stehouwer CDA, et al: The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the metabolic syndrome-an analysis by structural equation modeling. Int J Obes. 2002, 26: 994-1008. 10.1038/sj.ijo.0802017.CrossRef Chan JCN, Cheung JCK, Stehouwer CDA, et al: The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the metabolic syndrome-an analysis by structural equation modeling. Int J Obes. 2002, 26: 994-1008. 10.1038/sj.ijo.0802017.CrossRef
Metadata
Title
Disassociated relation between plasma tumor necrosis factor-α, interleukin-6 and increased body weight in Amerindian women: A long-term prospective study of natural body weight variation and impaired glucose tolerance
Authors
Folke Lindgärde
Anders Gottsäter
Bo Ahrén
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2010
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-2-38

Other articles of this Issue 1/2010

Diabetology & Metabolic Syndrome 1/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.